Keynote Speakers

Edit I. Buzás, MD, PhD, is Professor and Head of the Department of Genetics, Cell- and Immunobiology at Semmelweis University, Budapest, Hungary. Her earlier research, conducted at the University of Debrecen (Hungary), McGill University (Montreal, Canada), and Rush University (Chicago, IL, USA), focused on autoimmunity. Over the past two decades, her research at Semmelweis University has centered on extracellular vesicles. Together with her team, she was the first to demonstrate that protein aggregates and LDL can mimic extracellular vesicles during isolation, and that DNA, LDL, and proteins spontaneously associate with the surface of EVs as components of a biomolecular corona. She organized the ISEV Workshop on EV Isolation and Characterization in 2013 (Hungary), served as Chair of the ISEV2016 Annual Meeting in Rotterdam, and co-organized both the Gordon Research Conference on EVs in 2024 (USA) and the ISEV Biomolecular Corona Workshop in 2025 (Italy). She has served as an Associate Editor of the Journal of Extracellular Vesicles, received the ISEV Special Achievement Award, and was President of ISEV from 2022 to 2024. She is a member of the Academia Europaea and the Hungarian Academy of Sciences, and currently serves as President of the Hungarian Society for Immunology.

Dr. Yáñez-Mó leads the “Tetraspanin-enriched membrane microdomains in extracellular vesicles and cell adhesion and migration” group at Universidad Autónoma de Madrid. Her research explored the role of tetraspanins in adhesion-related biological processes, such as antigen presentation, leukocyte extravasation, HIV infection, and embryo implantation. She has more recently focused on extracellular vesicles, elucidating the role of tetraspanins in their biogenesis and cargo selection. Her team also established a biotechnological line, optimizing tools targeting tetraspanins for extracellular vesicle detection devices and engineering artificial exosomes in collaboration with Spanish biotech companies.

Dr. Yáñez-Mó is founder member and current president of GEIVEX, the Spanish Society for EV Research (established in 2012). She organized the 1st European MOVE meeting in Malaga in 2023 and has been actively involved in the organizing committees of the International Society ISEV international meetings in 2016 and 2018.

Gisela D’Angelo is Research Director (DR2, HDR) at CNRS, working at Institut Curie in the Department of Cell Biology and Cancer (CNRS UMR144). She leads an independent project within the Structure and Membrane Compartments team headed by Graça Raposo.

After a postdoc at UCSF (1991–1995) in Richard Weiner’s lab, where she contributed to the first characterization of the VEGF signaling pathway, she returned to France and joined thè CNRS, studying angiogenesis using Drosophila as an in vivo model system. In 2005, she uncovered that Hedgehog morphogen is secreted on extracellular vesicles from epithelial cell microvilli.

Since moving to Institut Curie in 2017, she has focused on extracellular vesicle biogenesis, identifying protrusion-derived EVs and investigating their roles in intercellular communication in cancer.

Bernd Giebel studied biology in Cologne and received his PhD in 1996. He then joined the Heinrich-Heine-University of Düsseldorf in 1999, focusing on human hematopoietic stem and progenitor cells. In 2008, he transitioned to the University Hospital Essen, where his research expanded to extracellular vesicles (EVs). His work, particularly on mesenchymal stem/stromal cell-derived EVs (MSC-EVs), showcased their therapeutic potential in human graft-versus-host disease (GvHD) patients and various animal models. His primary goal is to efficiently translate MSC-EVs into clinical use, leading to his appointment as a full professor for Translational Extracellular Vesicle Research at the University Hospital Essen in 2023.

In additions, he aims to promote national and international EV research. In this context, Giebel served as the founding president of the German Society of Extracellular Vesicles (GSEV) from 2017 to 2023. Since 2018, he is co-chairing the exosome committee of the International Society of Gene and Cell Therapy (ISCT). Additionally, he is part of the scientific advisory board of the SME companies Mursla LTD and PL BioScience and a founding director of Exosla LTD.

Marca Wauben is head of Cell Biology, Faculty of Veterinary Medicine at Utrecht University. She is a pioneer in EV-mediated communication and an internationally recognized expert in EV-biology, isolation and characterization. Her research groupunveiled novel aspects of EV-mediated immune regulation, EV release, EV cargo sorting (proteins, RNAs, lipids and metabolites) and targeting. They pioneered in single EV-based flow cytometric analysis and developed EV isolation methods for different body fluids and protocols for EV-based multi-omics analysis. They unveiled the regulatory potential of human milk-derived EVs on different cell types in the gastrointestinal tract, and defined their EV-cargo-function relationships based on integrated functional and multi-omics analysis. Furthermore, they showed the added value of integrating EV-proteomics and lipidomics in the search for arthritis-associated EV-profiles in synovial fluid. Besides fundamental and biomarker EV-research, Marca Wauben is interested in (clinical) translation of EV-applications and is actively involved in many national and global EV-initiatives.

Eva-Maria Krämer-Albers received a PhD in molecular and cellular neurosciences from the University of Heidelberg/Germany and was further trained in neurogenetics at the Max Planck Institute of Experimental Medicine in Göttingen/Germany. Since 2004, Eva-Maria is heading a research group at the Johannes Gutenberg University in Mainz/Germany, studying the role of EVs in neuron-glia communication and long-term CNS integrity. Furthermore, she developed interest in the dynamics of EVs in the circulation and their potential role in interorgan communication in response to physical exercise as well as other forms of stress.   

Eva-Maria served as associate editor for the Journal of Extracellular Vesicles between 2012 and 2019 and as vice-president of the German Society of Extracellular Vesicles (GSEV) between 2017 and 2023. She is co-chairing ISEV2025, the Annual Meeting of the International Society of Extracellular Vesicles, held in Vienna.